Late HCC onset after direct antiviral agents therapy in patients with sustained virological response: do we need to reconsider their efficacy according to long term follow-up?

A. PerrellaVII Department Infectious Disease and Immunology, Ospedali dei Colli P.O. D.Cotugno, Naples, Italy; Correspondence[email protected]

A. IzziI Division Infectious Disease, Ospedali dei Colli P.O. D.Cotugno, Naples, Italy;

R. PunziVI Divisione Infectious Disease, Ospedali dei Colli P.O. D.Cotugno, Naples, Italy;

E. AdinolfiGastroenterology Unit, Università degli Studi della Campania “Luigi Vanvitelli”, Naples, Italy

C. SbregliaVII Department Infectious Disease and Immunology, Ospedali dei Colli P.O. D.Cotugno, Naples, Italy;

P. BellopedeVII Department Infectious Disease and Immunology, Ospedali dei Colli P.O. D.Cotugno, Naples, Italy;

A. Galeota LanzaVII Department Infectious Disease and Immunology, Ospedali dei Colli P.O. D.Cotugno, Naples, Italy;

F. MartucciVII Department Infectious Disease and Immunology, Ospedali dei Colli P.O. D.Cotugno, Naples, Italy;

L. RinaldiGastroenterology Unit, Università degli Studi della Campania “Luigi Vanvitelli”, Naples, Italy

show all

"Late HCC onset after direct antiviral agents therapy in patients with sustained virological response: do we need to reconsider their efficacy according to long term follow-up?." Scandinavian Journal of Gastroenterology, 53(8), pp. 1025–1026

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Late HCC onset after direct antiviral agents therapy in patients with sustained virological response: do we need to reconsider their efficacy according to long term follow-up?

Information for

Open access

Opportunities

Help and information

Late HCC onset after direct antiviral agents therapy in patients with sustained virological response: do we need to reconsider their efficacy according to long term follow-up?

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature